Aktuelni problemi u primeni mišićnih relaksanata u kliničkoj praksi [PDF]
Konstantinović Slavko, Balkanov Trajan
doaj +1 more source
Neuromuscular Blocking Agents and Monitoring in China: A Cross-Sectional Survey of Current Management. [PDF]
Wu H+7 more
europepmc +1 more source
The dose response effect of long-acting nondepolarizing neuromuscular blocking agents in children [PDF]
Nishan G. Goudsouzian+3 more
openalex +1 more source
Neutrophil activation in beta‐lactams (BL) immediate hypersensitivity reactions (IHR). Factor component analysis of IHR biomarkers suggests an IgG‐mediated mechanism. We propose Neutrophil Elastase as a biomarker of neutrophil activation in BL IHR. ABSTRACT Background Beta‐lactams (BLs) are the predominant cause of immediate allergic reactions to drugs.
Adrienne Astrid Gallizzi+13 more
wiley +1 more source
Factors Associated with the Underuse of Sedatives and Neuromuscular Blocking Agents for Pediatric Emergency Endotracheal Intubation in Korea. [PDF]
Lee JY+5 more
europepmc +1 more source
INTERACTION OF NEUROMUSCULAR BLOCKING AGENTS WITH HUMAN CHOLINESTERASES [PDF]
A. Deery+3 more
openalex +1 more source
Abstract Background Acquired equine polyneuropathy in Nordic horses (AEP) is the most prevalent equine polyneuropathy in Norway, Sweden, and Finland and is characterised by pelvic limb knuckling due to metatarsophalangeal extension dysfunction.
Anna May+6 more
wiley +1 more source
Neuromuscular blocking agents and opioids are major risk factors for developing pressure injuries in patients in the intensive care unit. [PDF]
Lee SY, Oh DK, Hong SB, Lim CM, Huh JW.
europepmc +1 more source
Abstract Botulism is a severe and often fatal disease in equine patients worldwide. Clostridium botulinum is a ubiquitous soil organism which produces a potent neurotoxin resulting in neuromuscular blockade and flaccid paralysis in affected animals. Definitive diagnosis is often impractical or impossible, leading to diagnosis and treatment based on ...
Kali Slavik+2 more
wiley +1 more source
Effective dose of remimazolam co-administered with remifentanil to facilitate I-gel insertion without neuromuscular blocking agents: an up-and-down sequential allocation trial. [PDF]
Oh J, Park SY, Lee GY, Park JH, Joe HB.
europepmc +1 more source